Resistant Hypertension: Incidence, Prevalence, and Prognosis

Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association

Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149

Resistant Hypertension: Diagnosis, Evaluation, and Treatment

Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,240

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

Jamerson, K., Weber, M. A., Bakris, G. L., Dahlöf, B., Pitt, B., Shi, V., Hester, A., Gupte, J., Gatlin, M., & Velazquez, E. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806182 · Cited by 2,065

Resistant Hypertension: Diagnosis, Evaluation, and Treatment

Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.189141 · Cited by 1,416

Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Cushman, W. C., Ford, C. E., Cutler, J. A., Margolis, K. L., Davis, B. R., Grimm, R. H., Black, H. R., Hamilton, B. P., Holland, J., Nwachuku, C., et al. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.02045.x · Cited by 979

Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients

Daugherty, S. L., Powers, J. D., Magid, D. J., Tavel, H. M., Masoudi, F. A., Margolis, K. L., O'Connor, P. J., Selby, J. V., & Ho, P. M. (2012) · Circulation · doi:10.1161/circulationaha.111.068064 · Cited by 930

Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring

de la Sierra, A., Segura, J., Banegas, J. R., Gorostidi, M., de la Cruz, J. J., Armario, P., Oliveras, A., & Ruilope, L. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168948 · Cited by 809

Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension

Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763

Prevalence of Resistant Hypertension in the United States, 2003–2008

Persell, S. D. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.170308 · Cited by 761

Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008

Egan, B. M., Zhao, Y., Axon, R. N., Brzezinski, W. A., & Ferdinand, K. C. (2011) · Circulation · doi:10.1161/circulationaha.111.030189 · Cited by 599

Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association

Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153

The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues

Laslett, L. J., Alagona, P., Clark, B. A., Drozda, J. P., Saldivar, F., Wilson, S. R., Poe, C., & Hart, M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.002 · Cited by 801

Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension

Dinh, Q. N., Drummond, G. R., Sobey, C. G., & Chrissobolis, S. (2014) · BioMed Research International · doi:10.1155/2014/406960 · Cited by 621

The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension

McBryde, F. D., Abdala, A. P., Hendy, E. B., Pijacka, W., Marvar, P. J., Moraes, D. J. A., Sobotka, P. A., & Paton, J. F. R. (2013) · Nature Communications · doi:10.1038/ncomms3395 · Cited by 247

Obligatory Role for B Cells in the Development of Angiotensin II–Dependent Hypertension

Chan, C. T., Sobey, C. G., Lieu, M., Ferens, D. M., Kett, M. M., Diep, H., Kim, H. A., Krishnan, S. M., Lewis, C., Salimova, E., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05779 · Cited by 246

Systematic Review and Meta-Analysis of the Prevalence of Resistant Hypertension in Treated Hypertensive Populations

Achelrod, D., Wenzel, U. O., & Frey, S. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu151 · Cited by 200

Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial

Lobo, M. D., Sobotka, P. A., Stanton, A. V., Cockcroft, J., Sulke, N., Dolan, E., van der Giet, M., Hoyer, J. D., FURNISS, S. S., Foran, J. P., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62053-5 · Cited by 177

Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality

Irvin, M. R., Booth, J. N., Shimbo, D., Lackland, D. T., Oparil, S., Howard, G., Safford, M. M., Muntner, P., & Calhoun, D. A. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.03.003 · Cited by 146

Obstructive Sleep Apnea and Hypertension: Updates to a Critical Relationship

BROWN, J., Yazdi, F., Jodari‐Karimi, M., Owen, J., & Reisin, E. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01181-w · Cited by 154

International Expert Consensus Statement

Schlaich, M. P., Schmieder, R. E., Bakris, G. L., Blankestijn, P. J., Böhm, M., Campese, V. M., Francis, D. P., Grassi, G. M., Hering, D., Katholi, R. E., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1616 · Cited by 139

When and How Should We Revascularize Patients With Atherosclerotic Renal Artery Stenosis?

Prince, M., Soto, J. T., & White, C. J. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2018.10.023 · Cited by 129

Clinical characteristics of patients with resistant hypertension: the RESIST-POL study

Florczak, E., Prejbisz, A., Szwench-Pietrasz, E., Śliwiński, P., Bieleń, P., Klisiewicz, A., Michałowska, I., Warchoł, E., Januszewicz, M., Kała, M., et al. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.32 · Cited by 120

Hypertension and obstructive sleep apnea

Cai, A., Wang, L., & Zhou, Y. (2016) · Hypertension Research · doi:10.1038/hr.2016.11 · Cited by 112

Trends for prevalence and incidence of resistant hypertension: population based cohort study in the UK 1995-2015

Sinnott, S., Smeeth, L. L., Williamson, E., & Douglas, I. (2017) · BMJ · doi:10.1136/bmj.j3984 · Cited by 87

Prevalence and Correlates of Low Medication Adherence in Apparent Treatment‐Resistant Hypertension

Irvin, M. R., Shimbo, D., Mann, D. M., Reynolds, K., Krousel-Wood, M. A., Limdi, N. A., Lackland, D. T., Calhoun, D. A., Oparil, S., & Muntner, P. (2012) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2012.00690.x · Cited by 80

Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level?

Lüscher, T. F., & Mahfoud, F. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu195 · Cited by 69

The Role of Obesity and Obstructive Sleep Apnea in the Pathogenesis and Treatment of Resistant Hypertension

Marcus, J. A., Pothineni, A., Marcus, C. Z., & Bisognano, J. D. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0411-y · Cited by 61

Translational Examination of Changes in Baroreflex Function After Renal Denervation in Hypertensive Rats and Humans

Hart, E. C., McBryde, F. D., Burchell, A. E., Ratcliffe, L. E. K., Stewart, L. Q., Baumbach, A., Nightingale, A. K., & Paton, J. F. R. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01261 · Cited by 61

UHPLC–MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients

Nicolò, A. D., Avataneo, V., Rabbia, F., Bonifacio, G., Cusato, J., Tomasello, C., Perlo, E., Mulatero, P., Veglio, F., Perri, G. D., et al. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.07.049 · Cited by 48

Therapeutic drug monitoring‐guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence

Avataneo, V., Nicolò, A. D., Rabbia, F., Perlo, E., Burrello, J., Berra, E., Pappaccogli, M., Cusato, J., D’Avolio, A., Perri, G. D., et al. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13706 · Cited by 48

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension

Tsujimoto, T., & Kajio, H. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018827 · Cited by 48

Renal Artery Stenosis: When to Revascularize in 2017

Soto, J. T., & White, C. J. (2017) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2017.01.004 · Cited by 44

Renal Artery Stenosis

Soto, J. T., & White, C. J. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.09.006 · Cited by 43

The burden of hypertension

Kintscher, U. (2013) · EuroIntervention · doi:10.4244/eijv9sra3 · Cited by 43

Interaction Between Pannexin 1 and Caveolin-1 in Smooth Muscle Can Regulate Blood Pressure

DeLalio, L. J., Keller, A., Chen, J., Boyce, A. K. J., Artamonov, M. V., Page, H. R. A., Keller, T. C. S., Johnstone, S. R., Weaver, R. B., Good, M. E., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311290 · Cited by 42

Garcinia mangostana pericarp extract protects against oxidative stress and cardiovascular remodeling via suppression of p47 phox and iNOS in nitric oxide deficient rats

Boonprom, P., Boonla, O., Chayaburakul, K., Welbat, J. U., Pannangpetch, P., Kukongviriyapan, U., Kukongviriyapan, V., Pakdeechote, P., & Prachaney, P. (2017) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2017.03.007 · Cited by 41

Renal Sympathetic Denervation Therapy for Resistant Hypertension

Myat, A., Redwood, S. R., Qureshi, A. C., Thackray, S. D. R., Cleland, J. G. F., Bhatt, D. L., Williams, B., & Gersh, B. J. (2013) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.000037 · Cited by 40

UHPLC–MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples

Nicolò, A. D., Avataneo, V., Rabbia, F., Sciandra, M., Tosello, F., Cusato, J., Perlo, E., Mulatero, P., Veglio, F., Perri, G. D., et al. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.05.018 · Cited by 39

Resistant Hypertension and Associated Comorbidities in a Veterans Affairs Population

Acharya, T., Tringali, S., Singh, M., & Huang, J. (2014) · The Journal of Clinical Hypertension · doi:10.1111/jch.12410 · Cited by 38

Resistant Hypertension Optimal Treatment Trial: A Randomized Controlled Trial

The ReHOT Investigators (2013) · Clinical Cardiology · doi:10.1002/clc.22228 · Cited by 38

Independent association of obstructive sleep apnea with left ventricular geometry and systolic function in resistant hypertension: the RESIST-POL study

Dobrowolski, P., Klisiewicz, A., Florczak, E., Prejbisz, A., Bieleń, P., Śliwiński, P., Kabat, M., Rybicka, J., Topór‐Mądry, R., Januszewicz, A., et al. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.06.015 · Cited by 37

Hypertensive Crisis in Pediatric Patients: An Overview

Raina, R., Mahajan, Z., Sharma, A., Chakraborty, R., Mahajan, S., Sethi, S. K., Kapur, G., & Kaelber, D. C. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.588911 · Cited by 39

Resistant hypertension and the neglected antihypertensive: sodium restriction

Agarwal, R. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs384 · Cited by 35

Pharmacological potentiation of the efferent vagus nerve attenuates blood pressure and renal injury in a murine model of systemic lupus erythematosus

Pham, G. S., Wang, L. A., & Mathis, K. W. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00362.2017 · Cited by 36

Patients with treatment-resistant hypertension report increased stress and anxiety

Schmieder, R. E., Grassi, G. M., & Kjeldsen, S. E. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835d6e53 · Cited by 34

Coronary flow reserve in patients with resistant hypertension

Völz, S., Svedlund, S., Andersson, B., Li-Ming, G., & Rundqvist, B. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-1043-4 · Cited by 33

Demografía y características clínicas de la hipertensión resistente en 6.292 pacientes en atención primaria

Gijón‐Conde, T., Graciani, A., & Banegas, J. R. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.09.029 · Cited by 32

The ROX coupler: Creation of a fixed iliac arteriovenous anastomosis for the treatment of uncontrolled systemic arterial hypertension, exploiting the physical properties of the arterial vasculature

Foran, J. P., Jain, A., Casserly, I. P., Kandzari, D. E., Rocha‐Singh, K. J., Witkowski, A., Katzen, B. T., Deaton, D., Balmforth, P., & Sobotka, P. A. (2014) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25707 · Cited by 32

NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating Hypertension

Keck, M., de Almeida, H., Compère, D., Inguimbert, N., Flahault, A., Balavoine, F., Roques, B. P., & Llorens‐Cortés, C. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12499 · Cited by 32

Targeting the Sympathetic Nervous System

Schlaich, M. P., Esler, M., Fink, G. D., Osborn, J. W., & Euler, D. E. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02144 · Cited by 31

Predictors of Uncontrolled Hypertension in the Stroke Belt

Dave, G., Bibeau, D. L., Schulz, M. R., Aronson, R. E., Ivanov, L. L., Black, A., & Spann, L. I. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12122 · Cited by 31

Resistant Hypertension: Demography and Clinical Characteristics in 6292 Patients in a Primary Health Care Setting

Gijón‐Conde, T., Graciani, A., & Banegas, J. R. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.09.027 · Cited by 28

Physician Underutilization of Effective Medications for Resistant Hypertension at Office Visits in the United States: NAMCS 2006–2010

Fontil, V., Pletcher, M. J., Khanna, R. R., Guzman, D., Victor, R. G., & Bibbins-Domingo, K. B. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2683-y · Cited by 27

Resistant Hypertension in Nondialysis Chronic Kidney Disease

Borrelli, S., Nicola, L. D., Stanzione, G., Conte, G., & Minutolo, R. (2013) · International Journal of Hypertension · doi:10.1155/2013/929183 · Cited by 27

Cost Effectiveness of Renal Denervation Therapy for the Treatment of Resistant Hypertension in the UK

Gladwell, D., Henry, T., Cook, M., & Akehurst, R. L. (2014) · Applied Health Economics and Health Policy · doi:10.1007/s40258-014-0116-7 · Cited by 27

Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHAT

Lynch, A. I., Irvin, M. R., Davis, B. R., Ford, C. E., Eckfeldt, J. H., & Arnett, D. K. (2013) · International Journal of Hypertension · doi:10.1155/2013/578578 · Cited by 26

Resistant Hypertension

Carey, R. M. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00601 · Cited by 28

Characterization of Individuals With Apparent Resistant Hypertension Using Contemporary Guidelines: Insights From CV-QUIC

Ebinger, J. E., Gluckman, T. J., Magraner, J., Chiu, S. T., Rider, D., Thomas, C., Das, S. R., Ho, P. M., Shreenivas, S., & Bradley, S. M. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.20894 · Cited by 26

Renal Denervation and Celiac Ganglionectomy Decrease Mean Arterial Pressure Similarly in Genetically Hypertensive Schlager (BPH/2J) Mice

Asirvatham-Jeyaraj, N., Gauthier, M. M., Banek, C. T., Ramesh, A., Garver, H., Fink, G. D., & Osborn, J. W. (2021) · Hypertension · doi:10.1161/hypertensionaha.119.14069 · Cited by 24

Munchausen syndrome

Pessina, A. C., Bisogni, V., Fassina, A., & Rossi, G. P. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328360e9ae · Cited by 23

Resistant Hypertension and Risk of Adverse Events in Individuals With Type 1 Diabetes: A Nationwide Prospective Study

Lithovius, R., Harjutsalo, V., Mutter, S., Gordin, D., Forsblom, C. M., Groop, P., & FinnDiane Study Group (2020) · Diabetes Care · doi:10.2337/dc20-0170 · Cited by 23

Obstructive sleep apnea syndrome and sleep quality in hypertensive patients

Bacci, M. R., Emboz, J. N. M., Alves, B. D. C. A., da Veiga, G. L., Murad, N., Meneghini, A., Chagas, A. C. P., & Fonseca, F. L. A. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.12.1055 · Cited by 22

Prognostic Importance of Resistant Hypertension in Patients With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study

Cardoso, C. R. L., Leite, N. C., Bacan, G., Santos, D. A., Gorgonio, L. K. C., & Salles, G. F. (2019) · Diabetes Care · doi:10.2337/dc19-1534 · Cited by 21

Prognostic value of coronary vascular dysfunction assessed by rubidium-82 PET/CT imaging in patients with resistant hypertension without overt coronary artery disease

Gaudieri, V., Mannarino, T., Zampella, E., Assante, R., D’Antonio, A., Nappi, C., Cantoni, V., Green, R., Petretta, M., Arumugam, P., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05239-w · Cited by 21

Management of Hypertension in Primary Care Safety‐Net Clinics in the United States: A Comparison of Community Health Centers and Private Physicians' Offices

Fontil, V., Bibbins-Domingo, K. B., Nguyen, O. K., Guzman, D., & Goldman, L. E. (2016) · Health Services Research · doi:10.1111/1475-6773.12516 · Cited by 21

Antihypertensive Treatment and Resistant Hypertension in Patients With Type 1 Diabetes by Stages of Diabetic Nephropathy

Lithovius, R., Harjutsalo, V., Forsblom, C. M., Saraheimo, M., Groop, P., & on behalf of the FinnDiane Study Group (2013) · Diabetes Care · doi:10.2337/dc13-2023 · Cited by 21

Pseudoresistant hypertension due to poor medication adherence

de Oliveira‐Filho, A. D., Costa, F. A., Neves, S. J. F., de Lyra, D. P., & Morisky, D. E. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.181 · Cited by 20

Treatment Resistant Hypertension

Weber, F., & Anlauf, M. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0425 · Cited by 20

Renal denervation in the era of HTN-3. Comprehensive review and glimpse into the future

Silva, J., Costa, M. A. D. S., Gersh, B. J., & Gonçalves, L. M. M. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.05.009 · Cited by 20

Renal denervation for the management of resistant hypertension

Patel, H. C., Hayward, C., Vassiliou, V. S., Patel, K., Howard, J. P., & Mario, C. D. (2015) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s65632 · Cited by 19

Apparent Treatment-Resistant Hypertension and Cardiovascular Risk in Hemodialysis Patients: Ten-Year Outcomes of the Q-Cohort Study

Tanaka, S., Ninomiya, T., Hiyamuta, H., Taniguchi, M., Tokumoto, M., Masutani, K., Ooboshi, H., Nakano, T., Tsuruya, K., & Kitazono, T. (2019) · Scientific Reports · doi:10.1038/s41598-018-37961-1 · Cited by 16

Cost-effectiveness of renal denervation therapy for the treatment of resistant hypertension in The Netherlands

Henry, T., Brouwer, B. F. E. D., van Keep, M., Blankestijn, P. J., Bots, M. L., & Koffijberg, H. (2014) · Journal of Medical Economics · doi:10.3111/13696998.2014.978453 · Cited by 18

Oh, the places you'll go! My many colored serotonin (apologies to Dr. Seuss)

Watts, S. W. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00538.2016 · Cited by 18

Characteristics and treatment of African-American and European-American patients with resistant hypertension identified using the electronic health record in an academic health centre: a case−control study

Shuey, M. M., Gandelman, J. S., Chung, C. P., Nian, H., Yu, C., Denny, J. C., & Brown, N. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021640 · Cited by 19

Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24

Flack, J. M., Azizi, M., Brown, J. M., Dwyer, J. P., Jones, E. S. W., Lihn, A. S., Liu, L., Olsson, D. S., Perl, S., Shibata, H., et al. (2025) · Hypertension Research · doi:10.1038/s41440-025-02297-7 · Cited by 19

Novel formylpeptide receptor 1/2 agonist limits hypertension-induced cardiovascular damage

Singh, J., Jackson, K. L., Fang, H., Gumanti, A., Claridge, B., Tang, F. S., Kiriazis, H., Salimova, E., Parker, A. M., Nowell, C. J., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae103 · Cited by 17

The δ subunit of epithelial sodium channel in humans—a potential player in vascular physiology

Paudel, P., McDonald, F. J., & Fronius, M. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00800.2020 · Cited by 17

Catheter-based renal denervation in the treatment of resistant hypertension

Stouffer, G. A., DiBona, G. F., Patel, A. D., Kaul, P., & Hinderliter, A. L. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.04.027 · Cited by 16

Orally Active Aminopeptidase A Inhibitor Prodrugs: Current State and Future Directions

Keck, M., Hmazzou, R., & Llorens‐Cortés, C. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0957-4 · Cited by 17

Quantitative analysis of renal arterial variations affecting the eligibility of catheter-based renal denervation using multi-detector computed tomography angiography

Song, W. H., Baik, J., Choi, E., Lee, H., Kim, H. H., Park, S., & Jeong, C. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-76812-w · Cited by 17

Efficacy of angiotensin receptor neprilysin inhibitor in Asian patients with refractory hypertension

Li, W., Gong, M., Yu, Q., Liu, R., Chen, K., Lv, W., Yao, F., Xu, Z., Xu, Y., Song, W., et al. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14454 · Cited by 14

Percutaneous Renal Sympathetic Denervation: 2013 and Beyond

Froeschl, M. P. V., Hadziomerovic, A., & Ruzicka, M. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.11.003 · Cited by 15

Predicting Renal Denervation Response in Resistant High Blood Pressure by Arterial Stiffness Assessment: A Systematic Review

Burlacu, A., Brinza, C., Floria, M., Stefan, A.-E., Covic, A. S., & Covic, A. C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164837 · Cited by 14

Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study

Bhatt, H., Gamboa, C. M., Safford, M. M., Soliman, E. Z., & Glasser, S. P. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.05.007 · Cited by 14

The many faces of hypertension in individuals with type 1 diabetes

Lithovius, R., & Groop, P. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110564 · Cited by 15

Novel Dual Endothelin Inhibitors in the Management of Resistant Hypertension

Boutari, C., & Siskos, F. (2023) · Life · doi:10.3390/life13030806 · Cited by 14

Blood Pressure Goals and Targets in the Elderly

Aronow, W. S. (2015) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-015-0394-x · Cited by 14

Renal Innervation in Resistant Hypertension: A Review of Pathophysiology and Renal Denervation as Potential Treatment

Wilson, A. L., Gandhi, J., Suh, Y., Joshi, G. S., Smith, N. L., & Khan, S. A. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190301154100 · Cited by 13

Renal Denervation Therapy for the Treatment of Resistant Hypertension: A Position Statement by the Canadian Hypertension Education Program

Khan, N. A., Herman, R. J., Quinn, R. R., Rabkin, S. W., Ravani, P., Tobe, S. W., Feldman, R. D., Wijeysundera, H. C., & Padwal, R. S. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.07.008 · Cited by 12

Arterial Destiffening Starts Early after Renal Artery Denervation

Berūkštis, A., Navickas, R., Neverauskaitė-Piliponienė, G., Ryliškytė, L., Misiūra, J., Vajauskas, D., Misonis, N., & Laucevičius, A. (2019) · International Journal of Hypertension · doi:10.1155/2019/3845690 · Cited by 12

Renal revascularization in resistant hypertension

Prince, M., Gupta, A. A., Bob‐Manuel, T., & Soto, J. T. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.12.001 · Cited by 12

Desnervação renal em doentes com hipertensão arterial resistente: resultados aos seis meses de seguimento

Dores, H., Almeida, M., Gonçalves, P. D. A., Branco, P. Q., Gaspar, A., Sousa, H., Gomes, Â. C., Andrade, M. J., Carvalho, M. S., Teles, R. C., et al. (2014) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2013.09.008 · Cited by 12

Gender Difference of Blood Pressure Control Rate and Clinical Prognosis in Patients With Resistant Hypertension: Real-World Observation Study

Joo, H. J., Yum, Y., Kim, Y., Son, J., Kim, S. H., Choi, S., Han, S., Shin, M., Jeong, J., Kim, E. J., et al. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e124 · Cited by 12

Renal denervation using focused infrared fiber lasers: A potential treatment for hypertension

Alexander, V. V., Shi, Z., Iftekher, F., Welsh, M. J., Gurm, H. S., Rising, G. M., Yanovich, A., Walacavage, K., & Islam, M. N. (2014) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22290 · Cited by 11

Improvement in All‐Cause Mortality With Blood Pressure Control in a Group of US Veterans With Drug‐Resistant Hypertension

Fatemi, O., Goa, C., Faselis, C. J., Kokkinos, P. F., & Papademetriou, V. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12672 · Cited by 11

A qualitative comparison of high and low adherers with apparent treatment-resistant hypertension

Durand, H., Casey, M., Glynn, L. G., Hayes, P., Murphy, A. W., & Molloy, G. J. (2019) · Psychology Health & Medicine · doi:10.1080/13548506.2019.1619788 · Cited by 11

CrossTalk opposing view: Which technique for controlling resistant hypertension? Carotid chemoreceptor denervation/modulation

Ratcliffe, L. E. K., Pijacka, W., McBryde, F. D., Abdala, A. P., Moraes, D. J. A., Sobotka, P. A., Hart, E. C., Narkiewicz, K., Nightingale, A. K., & Paton, J. F. R. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.268227 · Cited by 10

Effects of PDE type 5 inhibitors on Left Ventricular Diastolic Dysfunction in Resistant Hypertension

de Faria, A. P., Modolo, R., Moreno, B. V. D., & Moreno, H. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20140159 · Cited by 10

Clinical application of interventional renal sympathetic denervation: recommendations of the Austrian Society of Hypertension 2012

Weber, T., Zweiker, R., Watschinger, B., Grüner, P., Koppelstätter, C., Brandt, M. C., Horina, J. H., Brussee, H., Hohenstein, K., Lambert, T., et al. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0257-3 · Cited by 10

Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study

for the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group, Solini, A., Penno, G., Orsi, E., Bonora, E., Fondelli, C., Trevisan, R., Vedovato, M., Cavalot, F. L., Lamacchia, O., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1313-x · Cited by 10

Renal denervation: Alternative treatment options for hypertension?

Gupta, A. A., Prince, M., Bob‐Manuel, T., & Jenkins, J. S. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.12.007 · Cited by 10

Increased Lipoprotein-associated phospholipase A2 activity portends an increased risk of resistant hypertension

Li, Z., Liu, J., Shen, Y., Zeng, F., & Zheng, D. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0184-9 · Cited by 10

How can resistant hypertension be identified and prevented?

Solini, A., & Ruilope, L. M. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.23 · Cited by 9

Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!

Maiolino, G., Azzolini, M., & Rossi, G. P. (2015) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2015.00003 · Cited by 9

Prevalence of resistant hypertension and associated factors in Japanese subjects with type 2 diabetes

Yokoyama, H., Araki, S., Watanabe, S., Honjo, J., Okizaki, S.-I., Yamada, D., Shudo, R., Shimizu, H., Sone, H., & Haneda, M. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.08.007 · Cited by 10

Plasma endothelin-1 levels in patients with resistant hypertension: effects of renal sympathetic denervation

Petramala, L., Olmati, F., Mancone, M., Concistrè, A., Galassi, M., Marinelli, C., Tonnarini, G., Lucia, P., Costi, U., Iannucci, G., et al. (2017) · Annals of Medicine · doi:10.1080/07853890.2017.1282623 · Cited by 9

Effects of renal sympathetic denervation on myocardial structure, function and perfusion: A serial CMR study

Delacroix, S., Chokka, R. G., Nelson, A. J., Wong, D. T. L., Pederson, S., Nimmo, J., Rajwani, A., Williams, K., Teo, K. S. L., & Worthley, S. G. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.03.022 · Cited by 9

How Does Preexisting Hypertension Affect Patients with Intracerebral Hemorrhage?

Valentine, D., Lord, A. S., Torres, J., Frontera, J. A., Ishida, K., Czeisler, B. M., Lee, F., Rosenthal, J., Calahan, T., & Lewis, A. K. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.11.023 · Cited by 9

Catheter-based Renal Sympathetic Denervation – Long-term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives

Mahfoud, F., Schmieder, R. E., Davies, J. E., Kandzari, D. E., Weil, J., & Whitbourn, R. (2013) · Interventional Cardiology Reviews Research Resources · doi:10.15420/icr.2013.8.2.118 · Cited by 9

Arterial Hypertension and Cardiopulmonary Function: The Value of a Combined Cardiopulmonary and Echocardiography Stress Test

Punta, L. D., Biase, N. D., Balletti, A., Filidei, F., Pieroni, A., Armenia, S., Mengozzi, A., Mazzola, M., Fiore, V. D., Dini, F. L., et al. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-021-00494-2 · Cited by 8

Muscling in on Resistant Hypertension

Valenzuela, P. L., Ruilope, L. M., & Lucía, A. (2020) · Circulation · doi:10.1161/circulationaha.119.044378 · Cited by 2

Resistant Hypertension: Overview

Krishnakumar, K. (2019) · Hypertension Journal · doi:10.15713/ins.johtn.0147

Resistant Hypertension - A Quandary of its Own.

Chandni, R. (2019) · PubMed

Redefining Resistant Hypertension

Smith, S. M., Gurka, M. J., Winterstein, A. G., Handberg, E. M., Pepine, C. J., & Cooper‐DeHoff, R. M. (2020) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.005979 · Cited by 4

Resistant Hypertension or Resistant Prescribing?

Ernst, M. E. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.183459 · Cited by 7